Literature DB >> 17059838

Cocaine increases 5-HT1B mRNA in rat nucleus accumbens shell neurons.

B J Hoplight1, E S Vincow, J F Neumaier.   

Abstract

Serotonin 5-HT(1B) receptors modulate behavioral responses to cocaine, but the effects of cocaine on endogenous 5-HT(1B) receptor expression are not known. Therefore, we examined the effect of binge cocaine administration on 5-HT1B mRNA expression in rat brain. We found that chronic, but not acute, binge cocaine exposure increased 5-HT(1B) mRNA by approximately 80% in nucleus accumbens shell and dorsal striatum. Surprisingly, 5-HT(1B) mRNA was increased in nucleus accumbens shell after chronic vehicle treatment as well, but this effect was driven by animals that were housed with cocaine-treated animals. Thus, 5-HT(1B) mRNA is upregulated by repeated exposure to cocaine and perhaps by social stress as well; both of these factors are relevant to the risk for relapse in cocaine addiction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17059838     DOI: 10.1016/j.neuropharm.2006.08.013

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  18 in total

1.  5-HT1B mRNA expression after chronic social stress.

Authors:  Amy R Furay; Ross A McDevitt; Klaus A Miczek; John F Neumaier
Journal:  Behav Brain Res       Date:  2011-06-21       Impact factor: 3.332

2.  Differential effect of viral overexpression of nucleus accumbens shell 5-HT1B receptors on stress- and cocaine priming-induced reinstatement of cocaine seeking.

Authors:  Sunila G Nair; Amy R Furay; Yusha Liu; John F Neumaier
Journal:  Pharmacol Biochem Behav       Date:  2013-09-25       Impact factor: 3.533

3.  MDMA self-administration fails to alter the behavioral response to 5-HT(1A) and 5-HT(1B) agonists.

Authors:  Dane Aronsen; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2016-02-09       Impact factor: 4.530

4.  Protracted withdrawal from cocaine self-administration flips the switch on 5-HT(1B) receptor modulation of cocaine abuse-related behaviors.

Authors:  Nathan S Pentkowski; Tim H C Cheung; William A Toy; Matthew D Adams; John F Neumaier; Janet L Neisewander
Journal:  Biol Psychiatry       Date:  2012-04-27       Impact factor: 13.382

5.  5-HT(1B) receptor inhibition of alcohol-heightened aggression in mice: comparison to drinking and running.

Authors:  Eric W Fish; Sara D McKenzie-Quirk; Makoto Bannai; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2007-12-11       Impact factor: 4.530

6.  Stimulation of 5-HT(1B) receptors enhances cocaine reinforcement yet reduces cocaine-seeking behavior.

Authors:  Nathan S Pentkowski; Jazmin I Acosta; Jenny R Browning; Elizabeth C Hamilton; Janet L Neisewander
Journal:  Addict Biol       Date:  2009-07-24       Impact factor: 4.280

7.  Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptor.

Authors:  Vincent Van Waes; Sarah Ehrlich; Joel A Beverley; Heinz Steiner
Journal:  Neuropharmacology       Date:  2014-09-16       Impact factor: 5.250

8.  Pairing mild stress with increased serotonin-1B receptor expression in the nucleus accumbens increases susceptibility to amphetamine.

Authors:  Susan M Ferguson; Nolan A Sandygren; John F Neumaier
Journal:  Eur J Neurosci       Date:  2009-10-08       Impact factor: 3.386

9.  Increased expression of 5-HT(1B) receptors by Herpes simplex virus gene transfer in septal neurons: New in vitro and in vivo models to study 5-HT(1B) receptor function.

Authors:  Céline Riegert; Anna Katharina Rothmaier; Jost Leemhuis; Timothy J Sexton; John F Neumaier; Jean-Christophe Cassel; Rolf Jackisch
Journal:  Brain Res Bull       Date:  2008-02-12       Impact factor: 4.077

Review 10.  HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory.

Authors:  Antonio Drago; Silvia Alboni; Nicoletta Brunello; Brunello Nicoletta; Diana De Ronchi; Alessandro Serretti
Journal:  Eur J Clin Pharmacol       Date:  2009-10-07       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.